Clinical use of cardiac PET/MRI: current state-of-the-art and potential future applications

[1]  P. Heusch,et al.  Feasibility of FDG-PET in myocarditis: Comparison to CMR using integrated PET/MRI , 2018, Journal of Nuclear Cardiology.

[2]  Deepak L. Bhatt,et al.  Integrated Noninvasive Physiological Assessment of Coronary Circulatory Function and Impact on Cardiovascular Mortality in Patients With Stable Coronary Artery Disease , 2017, Circulation.

[3]  K. Nikolaou,et al.  Cardiac MRI left ventricular global function index and quantitative late gadolinium enhancement in unrecognized myocardial infarction. , 2017, European journal of radiology.

[4]  P. Heusch,et al.  Evaluation of a low-carbohydrate diet-based preparation protocol without fasting for cardiac PET/MR imaging , 2017, Journal of Nuclear Cardiology.

[5]  V. Lorenzoni,et al.  Stress Perfusion CMR in Patients With Known and Suspected CAD: Prognostic Value and Optimal Ischemic Threshold for Revascularization. , 2017, JACC. Cardiovascular imaging.

[6]  Tobias Schaeffter,et al.  Cardiac and Respiratory Motion Correction for Simultaneous Cardiac PET/MR , 2017, The Journal of Nuclear Medicine.

[7]  M. Forsting,et al.  Integrated Assessment of Cardiac PET/MRI: Co-Registered PET and MRI Polar Plots by Mutual MR-Based Segmentation of the Left Ventricular Myocardium , 2017 .

[8]  J. Ferrières,et al.  Prognostic impact of non-compliance with guidelines-recommended times to reperfusion therapy in ST-elevation myocardial infarction. The FAST-MI 2010 registry , 2017, European heart journal. Acute cardiovascular care.

[9]  N. Alpert,et al.  Impact of motion and partial volume effects correction on PET myocardial perfusion imaging using simultaneous PET-MR , 2017, Physics in medicine and biology.

[10]  K. Nikolaou,et al.  Cardiovascular magnetic resonance patterns of biopsy proven cardiac involvement in systemic sclerosis , 2016, Journal of Cardiovascular Magnetic Resonance.

[11]  S. Nekolla,et al.  PET/MR Imaging in Heart Disease. , 2016, PET clinics.

[12]  Y. Takeishi,et al.  Simultaneous cardiac imaging to detect inflammation and scar tissue with 18F-fluorodeoxyglucose PET/MRI in cardiac sarcoidosis , 2016, Journal of Nuclear Cardiology.

[13]  Holger Cario,et al.  Noninvasive MRI-Based Liver Iron Quantification: Methodic Approaches, Practical Applicability and Significance , 2016, RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[14]  C. Ruiz-Frutos,et al.  Safety of regadenoson in patients with severe chronic obstructive pulmonary disease. , 2016, Revista espanola de medicina nuclear e imagen molecular.

[15]  M. Schuemie,et al.  Identifying Cases of Type 2 Diabetes in Heterogeneous Data Sources: Strategy from the EMIF Project , 2016, PloS one.

[16]  Antje Prasse.  The Diagnosis, Differential Diagnosis, and Treatment of Sarcoidosis. , 2016, Deutsches Arzteblatt international.

[17]  V. Sossi,et al.  Combined PET/MRI: from Status Quo to Status Go. Summary Report of the Fifth International Workshop on PET/MR Imaging; February 15–19, 2016; Tübingen, Germany , 2016, Molecular Imaging and Biology.

[18]  F. Schick,et al.  Signal decay mapping of myocardial edema using dual‐contrast fast spin‐echo MRI , 2016, Journal of magnetic resonance imaging : JMRI.

[19]  L. Cooper,et al.  Cardiac sarcoidosis , 2016, Journal of internal medicine.

[20]  P. Rajiah,et al.  Utility of late gadolinium enhancement in pediatric cardiac MRI , 2016, Pediatric Radiology.

[21]  M. Pomper,et al.  PET-measured longitudinal flow gradient correlates with invasive fractional flow reserve in CAD patients , 2016, European heart journal cardiovascular Imaging.

[22]  D. Pennell,et al.  Validation of T2* in-line analysis for tissue iron quantification at 1.5 T , 2016, Journal of Cardiovascular Magnetic Resonance.

[23]  Zhi-gang Yang,et al.  Regional myocardial microvascular dysfunction in cardiac amyloid light-chain amyloidosis: assessment with 3T cardiovascular magnetic resonance , 2016, Journal of Cardiovascular Magnetic Resonance.

[24]  M. Ng,et al.  Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry disease , 2016, Journal of Cardiovascular Magnetic Resonance.

[25]  P. Psaltis,et al.  Future imaging of atherosclerosis: molecular imaging of coronary atherosclerosis with (18)F positron emission tomography. , 2016, Cardiovascular diagnosis and therapy.

[26]  B. Lindahl,et al.  Unrecognized Myocardial Infarction Assessed by Cardiac Magnetic Resonance Imaging – Prognostic Implications , 2016, PloS one.

[27]  Oliver Lindner,et al.  Clinical use of quantitative cardiac perfusion PET: rationale, modalities and possible indications. Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[28]  S. Petersen,et al.  Cardiovascular magnetic resonance imaging of myocardial oedema following acute myocardial infarction: Is whole heart coverage necessary? , 2015, Journal of Cardiovascular Magnetic Resonance.

[29]  H. Verberne,et al.  Role of risk stratification by SPECT, PET, and hybrid imaging in guiding management of stable patients with ischaemic heart disease: expert panel of the EANM cardiovascular committee and EACVI. , 2015, European heart journal cardiovascular Imaging.

[30]  R. Loose,et al.  Functional and Morphological Parameters with Tissue Characterization of Cardiovascular Magnetic Imaging in Clinically Verified “Infarct-like Myocarditis” , 2015, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[31]  B. Wintersperger,et al.  Cardiovascular Imaging: The Past and the Future, Perspectives in Computed Tomography and Magnetic Resonance Imaging , 2015, Investigative radiology.

[32]  H. Quick,et al.  German Roentgen Society Statement on MR Imaging of Patients with Cardiac Pacemakers , 2015, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[33]  A. Sato,et al.  Coronary high-intensity plaque on T1-weighted magnetic resonance imaging and its association with myocardial injury after percutaneous coronary intervention. , 2015, European heart journal.

[34]  G. Krombach,et al.  T1, T2 Mapping and Extracellular Volume Fraction (ECV): Application, Value and Further Perspectives in Myocardial Inflammation and Cardiomyopathies , 2015, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[35]  J. Stehli,et al.  MR-based attenuation correction for cardiac FDG PET on a hybrid PET/MRI scanner: comparison with standard CT attenuation correction , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[36]  U. Kramer,et al.  Clinical and Histopathological Features of Patients with Systemic Sclerosis Undergoing Endomyocardial Biopsy , 2015, PloS one.

[37]  H. Zoller,et al.  Automatisierte Screening-Sequenz in der Beurteilung einer pathologischen Eiseneinlagerung und Verfettung der Leber: Vergleich mit konventioneller R2*-Relaxometrie und chemical-shift-Sequenz , 2015 .

[38]  S. Rauch,et al.  R2* Relaxometry for the Quantification of Hepatic Iron Overload: Biopsy-Based Calibration and Comparison with the Literature , 2015, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[39]  M. Forsting,et al.  Integrated FDG PET/MR Imaging for the Assessment of Myocardial Salvage in Reperfused Acute Myocardial Infarction. , 2015, Radiology.

[40]  A. Pisani,et al.  First experience of simultaneous PET/MRI for the early detection of cardiac involvement in patients with Anderson-Fabry disease , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[41]  Ian Law,et al.  Dental artifacts in the head and neck region: implications for Dixon-based attenuation correction in PET/MR , 2015, EJNMMI Physics.

[42]  T. Poeppel,et al.  Diagnosis and treatment response evaluation of cardiac sarcoidosis using positron emission tomography/magnetic resonance imaging. , 2015, European heart journal.

[43]  S. Lambova.  Cardiac manifestations in systemic sclerosis. , 2014, World journal of cardiology.

[44]  A. Bunck,et al.  [Abnormal gadolinium kinetics in cardio MRI - always an indication of cardiac amyloidosis?]. , 2014, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[45]  F. Nensa,et al.  Cardiovascular Hybrid Imaging using PET/MRI , 2014, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[46]  H. Kühl,et al.  Multimodale Tumorcharakterisierung mit PET/MRT: Korrelation von Tumorperfusion und 18F-FDG-Aufnahme bei Patienten mit NSCLC , 2014 .

[47]  M. Ishihara,et al.  High-intensity signals in coronary plaques on noncontrast T1-weighted magnetic resonance imaging as a novel determinant of coronary events. , 2014, Journal of the American College of Cardiology.

[48]  F. Bengel,et al.  Advanced Imaging of Cardiac Sarcoidosis , 2014, The Journal of Nuclear Medicine.

[49]  C. Kramer,et al.  Markedly increased volume of distribution of gadolinium in cardiac amyloidosis demonstrated by T1 mapping , 2013, Journal of magnetic resonance imaging : JMRI.

[50]  N. Funabashi,et al.  Determination of optimum periods between onset of suspected acute myocarditis and ¹⁸F-fluorodeoxyglucose positron emission tomography in the diagnosis of inflammatory left ventricular myocardium. , 2013, International journal of cardiology.

[51]  E. Nagel,et al.  Positron Emission Tomography/Computed Tomographic and Magnetic Resonance Imaging in a Murine Model of Progressive Atherosclerosis Using 64Cu-Labeled Glycoprotein VI-Fc , 2013, Circulation. Cardiovascular imaging.

[52]  D. Sobic-Saranovic,et al.  FDG PET imaging in sarcoidosis. , 2013, Seminars in nuclear medicine.

[53]  Jeroen J. Bax,et al.  2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. , 2013, European heart journal.

[54]  U. Kramer,et al.  Is myocardial stress perfusion MR-imaging suitable to predict the long term clinical outcome after revascularization? , 2013, European journal of radiology.

[55]  S Maderwald,et al.  Cardiac MRI: T2-Mapping Versus T2-Weighted Dark-Blood TSE Imaging for Myocardial Edema Visualization in Acute Myocardial Infarction , 2013, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[56]  P. Erba,et al.  FDG-PET in cardiac infections. , 2013, Seminars in nuclear medicine.

[57]  Tiina Heliö,et al.  Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.

[58]  C. Rischpler,et al.  PET/MRT in der Herzbildgebung , 2013, Der Radiologe.

[59]  Eric Vicaut,et al.  Platelet function testing to adjust antiplatelet therapy for elective coronary stenting: a landmark analysis of the ARCTIC trial , 2013 .

[60]  U. Kramer,et al.  Detection of Cardiovascular Disease in Elite Athletes Using Cardiac Magnetic Resonance Imaging , 2013, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[61]  M. Motwani,et al.  MR imaging of cardiac tumors and masses: a review of methods and clinical applications. , 2013, Radiology.

[62]  A. González,et al.  Dry Pericarditis, Diagnosis With Cardiac Magnetic Resonance Imaging , 2013 .

[63]  A. González,et al.  Pericarditis seca, diagnóstico con cardiorresonancia magnética , 2013 .

[64]  Martin Rajchl,et al.  Active Cardiac Sarcoidosis: First Clinical Experience of Simultaneous Positron Emission Tomography–Magnetic Resonance Imaging for the Diagnosis of Cardiac Disease , 2013, Circulation.

[65]  U. Kramer,et al.  CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. , 2013, JACC. Cardiovascular imaging.

[66]  S. Nekolla,et al.  Hybrid PET/MR Imaging of the Heart: Potential, Initial Experiences, and Future Prospects , 2013, The Journal of Nuclear Medicine.

[67]  S. Fürst,et al.  PET/MR: a paradigm shift , 2013, Cancer imaging : the official publication of the International Cancer Imaging Society.

[68]  L. Nilsson,et al.  Soluble TNF Receptors Are Associated with Infarct Size and Ventricular Dysfunction in ST-Elevation Myocardial Infarction , 2013, PloS one.

[69]  R. Berent,et al.  Klinischer Stellenwert und Indikationen zur Magnetresonanztomografie des Herzens 2013: Ein interdisziplinäres Expertenstatement , 2013, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[70]  M. Lubberink,et al.  In Vivo Visualization of Amyloid Deposits in the Heart with 11C-PIB and PET , 2013, The Journal of Nuclear Medicine.

[71]  S. Pavlović,et al.  The Utility of 18F-FDG PET/CT for Diagnosis and Adjustment of Therapy in Patients with Active Chronic Sarcoidosis , 2012, The Journal of Nuclear Medicine.

[72]  G. Adam,et al.  Improved Agreement between Experienced and Inexperienced Observers using a Standardized Evaluation Protocol for Cardiac Volumetry and Infarct Size Measurement , 2012, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[73]  M. Beer,et al.  Non-invasive Determination of Myocardial Lipid Content in Fabry Disease by 1H-MR Spectroscopy , 2012, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[74]  J. Bogaert,et al.  Post myocardial infarction of the left ventricle: the course ahead seen by cardiac MRI. , 2012, Cardiovascular diagnosis and therapy.

[75]  Lars Stegger,et al.  Differentiation of Malignant and Benign Cardiac Tumors Using 18F-FDG PET/CT , 2012, The Journal of Nuclear Medicine.

[76]  P. Kellman,et al.  Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. , 2012, JACC. Cardiovascular imaging.

[77]  K. Klingel,et al.  Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. , 2012, Journal of the American College of Cardiology.

[78]  K. Müllerleile,et al.  MRT des Herzens für Einsteiger , 2012 .

[79]  E. V. van Beek,et al.  Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. , 2012, Journal of the American College of Cardiology.

[80]  A. Huber,et al.  Konsensusempfehlungen der DRG/DGK/DGPK zum Einsatz der Herzbildgebung mit Computertomografie und Magnetresonanztomografie , 2012, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[81]  S. Sarikouch,et al.  Konsensusempfehlungen der DRG/DGK/DGPK zum Einsatz der Herzbildgebung mit Computertomografie und Magnetresonanztomografie , 2012, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[82]  Y. Yoon,et al.  Prognostic significance of unrecognized myocardial infarction detected with MR imaging in patients with impaired fasting glucose compared with those with diabetes. , 2012, Radiology.

[83]  R. Cury,et al.  Cardiac MR Imaging of Nonischemic Cardiomyopathies: Imaging Protocols and Spectra of Appearances. , 2012, Radiology.

[84]  C. Stanescu,et al.  Endocarditis in the 21(st) Century. , 2011, Maedica.

[85]  D Hahn,et al.  Right ventricular involvement in patients with Fabry's disease and the effect of enzyme replacement therapy. , 2011, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[86]  L. Adler,et al.  How to differentiate benign versus malignant cardiac and paracardiac 18F FDG uptake at oncologic PET/CT. , 2011, Radiographics : a review publication of the Radiological Society of North America, Inc.

[87]  S. Borges-Neto,et al.  Utility of FDG PET/CT in inflammatory cardiovascular disease. , 2011, Radiographics : a review publication of the Radiological Society of North America, Inc.

[88]  R. Blankstein,et al.  Stress myocardial perfusion imaging by CMR provides strong prognostic value to cardiac events regardless of patient's sex. , 2011, JACC. Cardiovascular imaging.

[89]  D. Shah,et al.  Primary cardiac tumors. , 2011, Texas Heart Institute journal.

[90]  Dimitrios Dougenis,et al.  Safety of magnetic resonance imaging in patients with implanted cardiac prostheses and metallic cardiovascular electronic devices. , 2011, The Annals of thoracic surgery.

[91]  M. Javadi,et al.  Prediction of Short-Term Cardiovascular Events Using Quantification of Global Myocardial Flow Reserve in Patients Referred for Clinical 82Rb PET Perfusion Imaging , 2011, The Journal of Nuclear Medicine.

[92]  W. Oyen,et al.  Imaging of Inflammation by PET, Conventional Scintigraphy, and Other Imaging Techniques , 2010, The Journal of Nuclear Medicine.

[93]  M. Javadi,et al.  Reference Ranges for LVEF and LV Volumes from Electrocardiographically Gated 82Rb Cardiac PET/CT Using Commercially Available Software , 2010, Journal of Nuclear Medicine.

[94]  N. Prakken,et al.  Screening for proximal coronary artery anomalies with 3-dimensional MR coronary angiography , 2010, The International Journal of Cardiovascular Imaging.

[95]  C. Claussen,et al.  High resolution myocardial magnetic resonance stress perfusion imaging at 3 T using a 1 M contrast agent , 2010, European Radiology.

[96]  Takahiro Higuchi,et al.  Cardiac positron emission tomography. , 2009, Journal of the American College of Cardiology.

[97]  E. Mayatepek,et al.  Fabry disease-often seen, rarely diagnosed. , 2009, Deutsches Arzteblatt international.

[98]  Stephan G. Nekolla,et al.  PET and MRI in cardiac imaging: from validation studies to integrated applications , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[99]  K. Fontaine,et al.  Cardiac Magnetic Resonance Imaging with Pharmacological Stress Perfusion and Delayed Enhancement in Asymptomatic Patients with Systemic Sclerosis , 2008, The Journal of Rheumatology.

[100]  J. Wood.  Cardiac iron across different transfusion-dependent diseases. , 2008, Blood reviews.

[101]  M. Fenchel,et al.  [Cardiac MRI in addition to MR angiography: a longitudinal study in vascular risk patients]. , 2008, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[102]  G. Kolodny,et al.  Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. , 2008, AJR. American journal of roentgenology.

[103]  M. Gutberlet,et al.  Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. , 2008, Radiology.

[104]  C O Ritter,et al.  [High-resolution MRI for the quantitative evaluation of subendocardial and subepicardial perfusion under pharmacological stress and at rest]. , 2007, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[105]  René M. Botnar,et al.  Coronary magnetic resonance angiography and vessel wall imaging in children with Kawasaki disease , 2007, Pediatric Radiology.

[106]  Raimund Erbel,et al.  Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. , 2004, European heart journal.

[107]  K. Kreitner,et al.  MRT des Herzens bei Verdacht auf Myokarditis , 2002 .

[108]  Patrick Clarysse,et al.  A review of cardiac image registration methods , 2002, IEEE Transactions on Medical Imaging.

[109]  F. M. Vogt,et al.  Myokardiale Vitalitätsdiagnostik mit kontrastverstärkter Magnetresonanztomographie - Vergleich des „late enhancement”-Konzepts mit der Positronen-Emissions-Tomographie , 2002 .

[110]  S. Globits,et al.  Magnetic resonance imaging evaluation of myocardial and pericardial disease , 1999, Journal of magnetic resonance imaging : JMRI.

[111]  U. Ruotsalainen,et al.  Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[112]  V. Fuster,et al.  Nuclear cardiology in the literature: A selection of recent, original research papers , 2018, Journal of Nuclear Cardiology.

[113]  K. Nikolaou,et al.  Improving CT-Based PET Attenuation Correction in the Vicinity of Metal Implants by an Iterative Metal Artifact Reduction Algorithm of CT Data and Its Comparison to Dual-Energy–Based Strategies: A Phantom Study , 2017, Investigative radiology.

[114]  J. Babb,et al.  Diagnostic Performance of Cardiac Magnetic Resonance Imaging and Echocardiography in Evaluation of Cardiac and Paracardiac Masses. , 2016, The American journal of cardiology.

[115]  Konstantin Nikolaou,et al.  Towards tracer dose reduction in PET studies: Simulation of dose reduction by retrospective randomized undersampling of list-mode data. , 2016, Hellenic journal of nuclear medicine.

[116]  L. Solnes,et al.  Role of PET/CT for the Identification of Cardiac Sarcoid Disease , 2015 .

[117]  Giuseppe Rubini,et al.  Current clinical use of 18FDG-PET/CT in patients with thoracic and systemic sarcoidosis , 2013, La radiologia medica.

[118]  S. Lensing,et al.  Utility of the inversion scout sequence (TI scout) in diagnosing myocardial amyloid infiltration , 2012, The International Journal of Cardiovascular Imaging.

[119]  Innere Medizin.  Myocarditis: Early Biopsy Allows for Tailored Regenerative Treatment , 2012 .

[120]  M. Javadi,et al.  Advances in PET myocardial perfusion imaging: F-18 labeled tracers , 2011, Annals of Nuclear Medicine.

[121]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .

[122]  Lisa M Ho,et al.  Conventional and reduced radiation dose of 16-MDCT for detection of nephrolithiasis and ureterolithiasis. , 2008, AJR. American journal of roentgenology.

[123]  Hsi-Yu Yu,et al.  First-pass myocardial perfusion cardiovascular magnetic resonance at 3 Tesla. , 2007, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[124]  S. Bergmann,et al.  Assessment of myocardial viability. , 2005, Seminars in nuclear medicine.

[125]  M. Nishimura,et al.  F-fluorodeoxyglucose Positron Emission Tomography (fdg Pet) and Cardiac Magnetic Resonance (cmr) in Corticosteroid-naive Patients with Conduction System Disease Due to Cardiac Sarcoidosis , 2022 .